MODIFIED HOST CELLS AND USES THEREOF

Described herein are modified host cells useful in the production of bioconjugates that can be used to vaccinate subjects against infection with Pseudomonas. The genomes of the modified host cells described herein comprise genes that encode proteins involved in glyosylation of proteins as well as ge...

Full description

Saved in:
Bibliographic Details
Main Authors Michael KOWARIK, Stefan J. KEMMLER, Julien L. QUÉBATTE, Christiane Marie- Paule Simone Jeanne FERON
Format Patent
LanguageEnglish
Spanish
Published 28.02.2017
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Described herein are modified host cells useful in the production of bioconjugates that can be used to vaccinate subjects against infection with Pseudomonas. The genomes of the modified host cells described herein comprise genes that encode proteins involved in glyosylation of proteins as well as genes specific to the production of Pseudomonas-specific antigens. Se describen aquí células huéspedes modificadas útiles en la producción de bioconjugados que se pueden usar para vacunar a sujetos contra la infección con Pseudomonas. Los genomas de las células huéspedes modificadas aquí descritas comprenden genes que codifican proteínas implicadas en la glicosilación de proteínas y también genes específicos para la producción antígenos específicos de Pseudomonas.
Bibliography:Application Number: MX20160013631